FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Sunday

 

Woman receives experimental treatment for MS: VIDEO























An afternoon by the pool is typical for Heather and her kids, but there was a time when  such an activity wouldn’t have been possible.   The mother of two didn’t feel comfortable watching her kids on her own.

"I couldn't walk.  I could drag my leg around. I had severe foot drop and spasticity. My hands were very numb and tingly all the time,” she said.

Heather—who has asked that her last name be withheld for privacy purposes—has relapsing remitting multiple sclerosis, the kind that gets worse over time.

FOX 35 first introduced viewers to Heather two years ago. At the time the MS was making it harder and harder for her to do just about everything.  Medications weren’t working, but she wasn’t willing to accept her quickly declining health.

“I was planning on going in a nursing home at the age of 26,” Heather said.

She decided to go to Northwestern Memorial Hospital in Chicago instead to have an experimental procedure called hematopoietic  stem cell transplantation -- or HSCT.  Everything changed.

"I have had no disease activity in two years.  I have been off medication for two and a half years.  I have been fine," she said in April of 2016.

Heather thinks she stopped her disease in its tracks.

“Before the transplant I could walk maybe 40 to 50 steps before I needed to hold on to something.  Now I walk anywhere from three to five thousand steps a day and I'm fine.”

HSCT involves aggressive chemotherapy and harvesting—then returning—the patient’s stem cells in order to reboot the immune system, which attacks the brain and spinal cord in people with MS.

"It's like flipping a switch,” Heather explained. “Just a quick response for the immune system that's been depleted really fast...bringing it back. Like...forget about those bad cells, we're going to reproduce with the good cells."

Dr. Richard Burt is leading the HSCT clinical trial.  He recently published his research in the Journal of the American Medical Association.

Researchers analyzed outcomes for 145 patients and found that 80 percent of them were attack-free for at least four years after the procedure.  About 87 percent of those patients stopped seeing their MS-related disability get worse.  More than half saw significant improvement in their disability.

Dr. David Honeycutt told FOX 35 HSCT “shows a lot of promise.”  Honeycutt is the medical director of the MS Center of Greater Orlando.  He hasn’t participated—or sent any patients to participate in—the HSCT clinical trial.  Honeycutt said experimental treatment can be an alternative for MS patients if nothing else is working.

"Those are the people that might be the ones who have failed pervious therapies that are already approved...that would consider a stem cell transplant at this point,” Honeycutt said.

That was the case Heather. She decided to try the experimental procedure, rather than accepting a life sentence with a debilitating disease.

Story Source: The above story is based on materials provided by FOX35
Note: Materials may be edited for content and length

Labels: , ,



Go to Newer News Go to Older News